menu search

astrazeneca sees £7bn wiped from its value as lung cancer results fall short of 'best-case scenario'

Shares in pharmaceutical giant astrazeneca PLC (LSE:AZN) fell 4.4% in early trading, erasing £7.3bn fr...

July 3, 2023, 4:19 am

astrazeneca reports positive results in late-stage trial of lung cancer therapy

British drugmaker astrazeneca said on Monday its anti-body drug for lung cancer had met two of its main...

July 3, 2023, 4:12 am

Genprex shares rise as fda grants third fast track designation for small cell lung cancer therapeutic reqorsa

Genprex, Inc. (NASDAQ:GNPX) shares moved higher in pre-market trading after the clinical-stage gene therapy company announced that the US Food and Dru...

June 28, 2023, 9:31 am

astrazeneca to spend $400 mln to plant 200 mln trees, cut carbon footprint

British drugmaker astrazeneca on Wednesday announced it would invest $400 million to plant over 200 mil...

June 28, 2023, 3:12 am

Is astrazeneca a top stock to buy right now?

Dividend-paying pharma stocks frequently deliver market-beating returns on capital. astrazeneca stock, ...

June 22, 2023, 2:00 pm

astrazeneca (azn) may reportedly spin-off its chinese business

astrazeneca (AZN) reportedly plans to spin-off its China business and list it separately in Hong Kong t...

June 20, 2023, 1:16 pm

astrazeneca may soon spin off its business in china

astrazeneca plc (LON: AZN) is considering spinning off its business in China, the Financial Times repor...

June 19, 2023, 10:36 am

astrazeneca reportedly mulling china spin-off

astrazeneca PLC (LSE:AZN), the UK's largest listed company, is considering carving out its China busine...

June 19, 2023, 4:12 am

2 best biotech stocks to buy right now

These European pharma giants have long-established records of success. astrazeneca has 12 medicines tha...

June 16, 2023, 10:07 am

Recursion pharmaceuticals: unlocking the future of biotech with ai-powered drug discovery

Recursion Pharmaceuticals presents a compelling investment opportunity due to its AI-driven drug discovery platform, solid financials, and diverse pip...

June 14, 2023, 12:21 am

astrazeneca (azn) breast cancer combo drug gets priority review

The FDA grants priority review status to astrazeneca's (AZN) capivasertib/Faslodex combination for the ...

June 13, 2023, 11:18 am

astrazeneca turns to cows to cut u.s. carbon footprint

Drugmaker astrazeneca is switching to biogas produced from cow manure and food waste in the United Stat...

June 13, 2023, 7:05 am

astrazeneca (azn) & quell to co-develop autoimmune cell therapies

astrazeneca (AZN) enters into a collaboration agreement with Quell Therapeutics to co-develop novel cel...

June 12, 2023, 10:58 am

Fda panel endorses astrazeneca (azn), sanofi's rsv antibody

The FDA's AMDAC unanimously recommends astrazeneca (AZN)/Sanofi's (SNY) nirsevimab as full immunization...

June 9, 2023, 2:58 pm

astrazeneca signs $2 bln agreement with quell to develop cell therapies

astrazeneca said on Friday it had signed an agreement with Quell Therapeutics potentially worth more th...

June 9, 2023, 4:03 am

astrazeneca places $85 million bet on autoimmune cell therapy with quell deal

astrazeneca PLC (LSE:AZN) is placing an $85 million bet on the autoimmune cell therapy sector with Q...

June 9, 2023, 3:11 am

Us fda panel backs sanofi-astrazeneca's preventive rsv therapy

The U.S. Food and Drug Administration advisers on Thursday backed the use of Sanofi and partner astrazeneca...

June 8, 2023, 4:32 pm

Fda advisers vote in favor of astrazeneca, sanofi antibody for infant rsv protection

Advisers to the U.S. Food and Drug Administration voted unanimously Thursday to recommend a monoclonal antibody developed by Sanofi SNY, +1.30% and ...

June 8, 2023, 4:23 pm

Fda advisors recommend astrazeneca antibody to protect babies from rsv

If the Food and Drug Administration approves nirsevimab, it will be the first medical intervention available in the U.S. that can protect infants from...

June 8, 2023, 3:18 pm

astrazeneca: broker upbeat after american cancer conference data reveal

astrazeneca PLC (LSE:AZN) presented significant new data at a recent global cancer conference, the Amer...

June 7, 2023, 7:16 am


Search within

Pages Search Results: